Summit Rock Advisors, LP Diversified Active

CIK: 0001540951 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Oct 26, 2021

Total Value ($000): $168,577 (100.0% shares, 0.0% debt)

Holdings (5)

IWN ISHARES TR 39.4%

Value ($000) $66,343 Shares 414,052 Est. Cost $165.77 Unrealized —

IUSV ISHARES TR 31.1%

Value ($000) $52,465 Shares 740,195 Est. Cost $54.56 Unrealized —

VTV VANGUARD INDEX FDS 28.0%

Value ($000) $47,119 Shares 348,077 Est. Cost $134.99 Unrealized —

CLOV CLOVER HEALTH INVESTMENTS CO 0.9%

Value ($000) $1,556 Shares 210,639 Est. Cost $8.56 Unrealized 0.0%

PHAT PHATHOM PHARMACEUTICALS INC 0.6%

Value ($000) $1,094 Shares 34,100 Est. Cost $38.42 Unrealized -13.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
IWN	ISHARES TR	414,052	$66,343	39.4%	$165.77	—	RUS 2000 VAL ETF	464287630
IUSV	ISHARES TR	740,195	$52,465	31.1%	$54.56	—	CORE S&P US VLU	464287663
VTV	VANGUARD INDEX FDS	348,077	$47,119	28.0%	$134.99	—	VALUE ETF	922908744
CLOV	CLOVER HEALTH INVESTMENTS CO	210,639	$1,556	0.9%	$8.56	0.0%	COM CL A	18914F103
PHAT	PHATHOM PHARMACEUTICALS INC	34,100	$1,094	0.6%	$38.42	-13.5%	COM	71722W107